Irritable Bowel Syndrome (IBS)

Latest News

ACG Provides Clinical Guideline on Irritable Bowel Syndrome

By

Colby Stong

The American College of Gastroenterology created guidelines to provide clinicians with evidence supporting the optimal management of patients with irritable bowel syndrome.

Novel Association Identified Between Brachyspira and IBS With Diarrhea

By

Virginia A. Schad, PharmD, RPh

A team of investigators sought to identify potential links between gut microbes and symptoms of irritable bowel syndrome.

Patients With Functional Dyspepsia May Be at Increased Risk for SIBO

By

Virginia A. Schad, PharmD, RPh

Investigators evaluated the prevalence of small intestinal bacterial overgrowth (SIBO) in a well-defined cohort of patients with functional dyspepsia (FD) using quantitative microbiological assessment of the duodenal aspirate.

Increasing GI Symptoms Seen in Approximately One-Third of Young Adults

By

Jessica Nye, PhD

Investigators sought to identify common GI symptoms in a large sample of “emerging adults” using the Patient-Reported Outcomes Measurement Information System – GI (PROMIS-GI) symptom scales.

Functional Constipation and IBS More Common in Pediatric Celiac Disease

By

Amit Akirov, MD

Celiac disease in children leads to an increased risk for functional constipation and irritable bowel syndrome compared with healthy controls.

UEG: Allergy-Related Dz Tied to Irritable Bowel Syndrome at 16

Asthma and food hypersensitivity (FH) at age 12 years are associated with an increased risk for irritable bowel syndrome at age 16 years.

Multidisciplinary Care Improves Symptoms Best in Functional GI Disorders

By

Brandon May

Researchers compared integrated multidisciplinary clinical care vs gastroenterologist-only care with regard to symptoms, specific functional disorders, psychological state, quality of life, and cost of care for treating functional gastrointestinal disorders.

Prevalence of Adverse Pregnancy Outcomes Assessed With Biologics for IBD

By

Cassandra Pardini, PharmD

The study aimed to determine the prevalence of adverse pregnancy outcomes associated with biologic use in women with IBD.

Poor Diagnostic Power of FBD With Colonoscopy

By

Jessica Nye, PhD

Investigators examined the diagnostic yield of colonoscopies for patients with functional bowel disorders without alarm features.

Malignancy Risk Low After Treating Long-Term With Tofacitinib for UC

By

Jessica Nye, PhD

Researchers assessed malignancy frequency in the tofacitinib ulcerative colitis clinical development program, along with frequency of malignancy events and rates.

Gut Microbiota Alterations Observed With Personalized IBS Treatment

By

Jessica Nye, PhD

Treatments guided by metagenomics may result in symptom improvement for patients with irritable bowel syndrome.

Acupuncture Possibly an Effective Therapy for Irritable Bowel Syndrome Symptoms

By

Jessica Nye, PhD

Use of acupuncture reduced total irritable bowel syndrome-Symptom Severity Score to a greater extent than use of other pharmacologic therapies.

Guideline Issued on the Use of Probiotics for Managing GI Disorders

By

Cassandra Pardini, PharmD

Probiotics should only be recommended for specific patient populations since there is not enough evidence to support their use in the majority of digestive conditions, according to new clinical guidelines released by the American Gastroenterological Association (AGA) and recently published in Gastroenterology.

IBS Frequency Higher in Patients With Acne

By

Brandon May

A novel study examines the relationship between acne vulgaris and irritable bowel syndrome.

Cannabis Use Associated with Fewer Hospital Readmissions in Patients with IBS

By

Kwamesha Joseph

Lower total hospitalization costs were identified in patients with IBS who used cannabis compared with patients who did not use cannabis.

Non-viable, Heat-inactivated Bifidobacterium bifidum MIMBb75 Improves IBS Symptoms

By

Dibash Kumar Das, PhD

Use of a heat-inactivated form of a probiotic was associated with significant reduction in abdominal pain as well as relief of symptoms in patients with irritable bowel syndrome.

Mindfulness-Based Stress Reduction May Cut IBS Symptoms

Mindfulness-based stress reduction training is associated with robust improvements in gastrointestinal symptoms for patients with irritable bowel syndrome.

Next-Gen Rechargeable Neurostimulator Implant Approved for Urinary, Bowel Dysfunction

By

Steve Duffy

The FDA has approved a new version of Axonics Modulation’s rechargeable implantable sacral neurostimulator (r-SNM) system that allows patients to decrease the frequency of charging to once a month.

Dead' Probiotic Treatment May Help Reduce Irritable Bowel Symptoms

Probiotic treatment with dead bacteria is better than placebo at alleviating symptoms of irritable bowel syndrome.

New Data on Peppermint Oil and Irritable Bowel Syndrome

By

Andy Kistler, MD, PharmD

A commonly used over-the-counter treatment for IBS is peppermint oil. The exact mechanism of action in IBS is not entirely known; however, it has been postulated that it may be mediated through smooth muscle relaxation, antimicrobial effects, modulation of pain receptors, and 5-hydroxytryptamine antagonism.